Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1997European Journal of CancerOpen Access

Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignancies

View Full Paper
Ask AI
Bookmark
Share

Authors

JNJ. NicholsFFFrancine M. FossDuke UniversityTKTimothy M. KuzelNorthwestern University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nichols et al. (1997) studied this question.

synapsesocial.com/papers/6a894e481fe1bad943eb1d5fhttps://doi.org/10.1016/s0959-8049(96)00327-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.1990 · 186 citations
  2. 2Expression of interleukin 2 receptors on activated human B cells.1984 · 486 citations
  3. 3Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma1987 · 90 citations